SCHEMBL785461

SCHEMBL785461

Cc1ccc(-c2ccco2)o1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.48
ADORA2A P29274 2/20 0.47
ADORA1 P30542 2/20 0.47
ADORA2B P29275 1/20 0.47
ADORA3 P0DMS8 1/20 0.46
S1PR4 O95977 1/20 0.44
TDP1 Q9NUW8 4/20 0.43
ALDH1A1 P00352 8/20 0.43
NPC1 O15118 6/20 0.43
RAB9A P51151 6/20 0.43
KDM4E B2RXH2 6/20 0.43
HPGD P15428 6/20 0.43
POLB P06746 4/20 0.43
MAPT P10636 4/20 0.43
HSD17B10 Q99714 4/20 0.43
L3MBTL1 Q9Y468 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
LMNA P02545 2/20 0.43
PKM P14618 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11974596 0.83 ALDH1A1 (0.52) TP53S1PR4TDP1ALDH1A1NPC1
SCHEMBL11974601 0.83 ALDH1A1 (0.52) TP53S1PR4TDP1ALDH1A1NPC1
SCHEMBL11974595 0.83 ALDH1A1 (0.52) TP53S1PR4TDP1ALDH1A1NPC1
SCHEMBL17951449 0.83 ALDH1A1 (0.52) TP53S1PR4TDP1ALDH1A1NPC1
SCHEMBL11974593 0.83 ALDH1A1 (0.52) TP53S1PR4TDP1ALDH1A1NPC1
SCHEMBL11974592 0.83 ALDH1A1 (0.52) TP53S1PR4TDP1ALDH1A1NPC1
SCHEMBL11974594 0.83 ALDH1A1 (0.52) TP53S1PR4TDP1ALDH1A1NPC1
SCHEMBL12578009 0.80 TDP1 (0.67) TP53ADORA2AADORA1TDP1ALDH1A1
SCHEMBL21365437 0.78 KDM4E (0.44) TP53S1PR4TDP1ALDH1A1NPC1
SCHEMBL10064162 0.77 TDP1 (0.62) TP53ADORA2AADORA1TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210057649-A1 PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING DEVICE SONY CORPORATION (JP) 2021-02-25 US disclosed
US-20200148541-A1 AN APPROACH TO A BOTTOM-UP SYNTHESIS OF NANOCARBONS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2020-05-14 US disclosed
US-20200148541-A1 AN APPROACH TO A BOTTOM-UP SYNTHESIS OF NANOCARBONS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2020-05-14 US disclosed
WO-2019203013-A1 PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING DEVICE ソニー株式会社 2019-10-24 WO disclosed
WO-2019053541-A1 ACRYLATES THROUGH OLEFIN/CARBON DIOXIDE COUPLING SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2019-03-21 WO disclosed
US-20190081251-A1 PHOTOELECTRIC CONVERSION ELEMENT AND SOLID-STATE IMAGING DEVICE SONY CORPORATION (JP) 2019-03-14 US disclosed
WO-2018220634-A1 AN APPROACH TO A BOTTOM-UP SYNTHESIS OF NANOCARBONS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) 2018-12-06 WO disclosed
WO-2017158469-A1 METHODS OF MAKING ALPHA, BETA-UNSATURATED CARBOXYLIC ACIDS OR SALTS SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2017-09-21 WO disclosed
US-8921582-B2 Oligo- and polyfurans, preparation and uses thereof YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2014-12-30 US disclosed
US-20140179934-A1 OLIGO- AND POLYFURANS, PREPARATION AND USES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2014-06-26 US disclosed
US-8759550-B2 Oligo- and polyfurans, preparation and uses thereof YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2014-06-24 US disclosed
US-20120209013-A1 OLIGO- AND POLYFURANS, PREPARATION AND USES THEREOF YEDA RESEARCH AND DEVELOPMENT CO.LTD (IL) 2012-08-16 US disclosed
US-20120068123-A1 USE OF PHTHALOCYANINE COMPOUNDS WITH ARYL OR HETARYL SUBSTITUENTS IN ORGANIC SOLAR CELLS BASF SE (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200148541-A1 AN APPROACH TO A BOTTOM-UP SYNTHESIS OF NANOCARBONS TYMS, NCL, PFAS TP53 1678/4885ADORA2A 3729/4885ADORA1 4505/4885
US-20140179934-A1 OLIGO- AND POLYFURANS, PREPARATION AND USES THEREOF PUF60, POLI, DHFR TP53 2314/4885ADORA2A 3569/4885ADORA1 3115/4885
US-20120068123-A1 USE OF PHTHALOCYANINE COMPOUNDS WITH ARYL OR HETARYL SUBSTITUENTS IN ORGANIC SOLAR CELLS RB1, NRAS, HLA-B TP53 353/4885ADORA2A 1251/4885ADORA1 1927/4885
US-20120209013-A1 OLIGO- AND POLYFURANS, PREPARATION AND USES THEREOF PUF60, POLI, DHFR TP53 2314/4885ADORA2A 3569/4885ADORA1 3115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.